Clinical Trials Logo

Stage 2 Hypertension clinical trials

View clinical trials related to Stage 2 Hypertension.

Filter by:
  • None
  • Page 1

NCT ID: NCT01508026 Completed - Clinical trials for Stage 2 Hypertension

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Start date: January 2012
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of fixed-dose combination of nebivolol and valsartan compared to monotherapy and placebo in patients with stage 1 and stage 2 hypertension.

NCT ID: NCT01368536 Terminated - Hypertension Clinical Trials

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

VALENCIA
Start date: May 2011
Phase: Phase 4
Study type: Interventional

This was a study to assess the safety and efficacy of Valturna and amlodipine or Valturna and chlorthalidone when compared to Valturna alone in patients with stage 2 hypertension and diabetes mellitus 2.

NCT ID: NCT00809926 Completed - Clinical trials for Stage 2 Hypertension

8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension

VANTAGE
Start date: January 2009
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of the valsartan/aliskiren combination compared to valsartan alone in patients with Stage 2 hypertension.